KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Markel (MKL) EBT (2016 - 2025)

Markel (MKL) has disclosed EBT for 16 consecutive years, with $734.2 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT rose 1.47% to $734.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.7 billion, a 24.88% decrease, with the full-year FY2025 number at $2.7 billion, down 24.88% from a year prior.
  • EBT was $734.2 million for Q4 2025 at Markel, down from $978.4 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $1.3 billion in Q1 2024 to a low of -$1.1 billion in Q2 2022.
  • A 5-year average of $599.8 million and a median of $731.1 million in 2021 define the central range for EBT.
  • Peak YoY movement for EBT: tumbled 210.0% in 2022, then soared 1687.11% in 2024.
  • Markel's EBT stood at $1.1 billion in 2021, then decreased by 20.97% to $898.7 million in 2022, then rose by 12.02% to $1.0 billion in 2023, then dropped by 28.14% to $723.5 million in 2024, then increased by 1.47% to $734.2 million in 2025.
  • Per Business Quant, the three most recent readings for MKL's EBT are $734.2 million (Q4 2025), $978.4 million (Q3 2025), and $862.4 million (Q2 2025).